Advanced search×

Impact of renin-angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy. Evidence from a study of genotyped patients.

Akira Funada, Tetsuo Konno, Noboru Fujino, Akihiko Muramoto, Kenshi Hayashi, Toshinari Tsubokawa, Kenji Sakata, Masa-Aki Kawashiri, Yoshiyu Takeda, Hidekazu Ino, and Masakazu Yamagishi

Circ J 74(12):2674-80 (2010) PMID 20975235

Although the renin-angiotensin system (RAS) can affect the development of left ventricular (LV) hypertrophy, few data exist regarding the relationships between RAS polymorphisms and alteration of LV function. The effect of RAS polymorphisms on LV function in genotyped hypertrophic cardiomyopathy (HCM) was examined in the present study.

Version: za2963e q8zaa q8zbd q8zcd q8zd7 q8ze3 q8zf3 q8zg9
PDF not found

Similar articles you may find interesting…

  1. A clinical prediction score for upper extremity deep venous thrombosis.
    Joel Constans, Louis-Rachid Salmi, ... Jean-Luc Bosson

    Thromb Haemost 99(1):202-7 (2008) PMID 18217155

    We propose a simple score to calculate clinical probability of UEDVT. This score might be a useful test in clinical trials as well as in clinical practice....
    Buy PDF
  2. Genetic analysis in a patient with recurrent cardiac myxoma and endocrinopathy.
    Yasushi Y Imai, Tsuyoshi T Taketani, ... Ryozo R Nagai

    Circ J 69(8):994-5 (2005) PMID 16041174

    A 60 year-old male was referred for treatment of a cardiac myxoma in the right atrium. He had a past history of left atrial cardiac myxoma at age 49 and pituitary microadenoma related to acromegaly at age 55. He did not have a family history of cardiac neoplasm or endocrinopathy. The intracardiac tu...
    PDF not found
  3. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV stu...
    Jean-Philippe JP Galanaud, Marie-Antoinette MA Sevestre-Pietri, ...

    Thromb Haemost 102(3):493-500 (2009) PMID 19718469

    We compared the risk factors and outcomes in patients with isolated symptomatic distal DVT with those with proximal symptomatic DVT. We analysed the data of patients with objectively confirmed symptomatic isolated DVT enrolled in the national (France), multicenter, prospective OPTIMEV study. This su...
    Buy PDF